硼法仑可用于硼中子俘获研究 (BNCT)，也可用于复发性或局部晚期头颈部癌症的研究。
包装:  500g/袋，1kg/袋，5kg/袋
供货情况: 现货供应
API Current Development Status: A3---Process Development / Scale-Up
Reference: 
Aktin major API development processes:
A1.Feasibility / Route Development
A2.Laboratory Process Development
A3.Process Development / Scale-Up
A4.GMP Clinical Development
A5.Commercial GMP Supply

[1].Coderre JA, Morris GM. The radiation biology of boron neutron capture therapy. Radiat Res. 1999;151(1):1-18.

[2].Barth RF, Soloway AH, Fairchild RG. Boron neutron capture therapy for cancer. Cancer Res. 1990;50(4):1061-1070.

[3].Barth RF, Vicente MG, Harling OK, et al. Current status of boron neutron capture therapy of cancer. Cancer Commun (Lond). 2018;38(1):35.

[4].Hirose K, Konno A, Hiratsuka J, et al. Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (^10B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial. Radiother Oncol. 2021;155:182-187.

[5].Ishiwata K. 4-Borono-2-[18F]-fluoro-L-phenylalanine PET for boron neutron capture therapy-oriented diagnosis. Ann Nucl Med. 2011;25(9):665-672.